Welcome to our dedicated page for Churchill Capital XIII news (Ticker: XIII), a resource for investors and traders seeking the latest updates and insights on Churchill Capital XIII stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Churchill Capital XIII's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Churchill Capital XIII's position in the market.
Churchill Capital Corp XIII (XIII) will allow separate trading of its Class A ordinary shares and warrants, beginning September 18, 2026, for holders of units issued in its IPO.
Unit holders may elect to separate the Class A ordinary shares and warrants included in the units. The separated Class A ordinary shares will trade on the Nasdaq Global Market under the symbol “XIII”, and the separated warrants will trade under “XIIIW”. Units that are not separated will continue to trade under “XIIIU”. No fractional warrants will be issued upon separation; only whole warrants will trade.
Churchill Capital Corp XIII is a blank check company formed to complete a business combination with one or more businesses in any industry.
Churchill Capital Corp XIII (Nasdaq: XIIIU) closed its upsized initial public offering of 41,400,000 units, including 5,400,000 units from the underwriter’s full over-allotment exercise, at $10.00 per unit, generating $414,000,000 in gross proceeds.
Each unit includes one Class A ordinary share and one-tenth of a redeemable warrant, with each whole warrant exercisable at $11.50 per share. According to the company, $414,000,000 (or $10.00 per public unit) was placed in a trust account. The SPAC, founded by Michael Klein, aims to complete a business combination in any sector.
Churchill Capital Corp XIII (Nasdaq: XIIIU) priced an upsized initial public offering of 36,000,000 units at $10.00 per unit, for gross proceeds of $360 million. Each unit includes one Class A ordinary share and one‑tenth of a redeemable warrant exercisable at $11.50 per share.
The units begin trading on the Nasdaq Global Market on July 30, 2026 under the symbol XIIIU, with shares and warrants expected to trade separately as XIII and XIIIW. Closing is expected on August 3, 2026, subject to customary conditions. Citigroup is sole book‑running manager, and the underwriter has a 45‑day option to buy up to 5,400,000 additional units. According to Churchill Capital Corp XIII, the SPAC was formed to pursue a business combination in any industry.